Stocks
Neurocrine Biosciences (NBIX) P/E US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 89.9 | 0.00 | 0.00 | 40.2 | 29.5 | 23.6 | ||
| Changes by years, y/y, % | +310% | -100% | -27% | +6.1% | |||||
Neurocrine Biosciences. P/E
Neurocrine Biosciences. P/E, changes, %
Neurocrine Biosciences (NBIX) P/E US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/E | ? | 36.1 | 35.7 | 32.6 | 29.5 | 19.8 | 23.6 | |
| Changes by years, y/y, % | +8% | -26% | -45% | |||||
| Changes by quarters, q/q, % | -10% | -1% | -9% | -10% | -33% | |||
